Targeting tumor-infiltrating regulatory T cells: combining CD47 and PD-L1 inhibition via a novel aptamer-siRNA chimera
Year: 2025
Type: article
Language: en
Topic: Phagocytosis and Immune Regulation
Authors and affiliations:
raw_author_name: Yu Zeng
raw_affiliation_strings: Phenome Research Center, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
raw_author_name: Xiaoli Chen
raw_affiliation_strings: Phenome Research Center, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
raw_author_name: Wenqiong Huang
raw_affiliation_strings: Phenome Research Center, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
raw_author_name: Chi Ho Chan
raw_affiliation_strings: Guangdong-Hong Kong-Macao Greater Bay Area International Research Platform for Aptamer-Based Translational Medicine and Drug Discovery, Hong Kong, China
Institute of Integrated Bioinformedicine and Translational Science (IBTS), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
raw_author_name: Ziqi Chen
raw_affiliation_strings: Guangdong-Hong Kong-Macao Greater Bay Area International Research Platform for Aptamer-Based Translational Medicine and Drug Discovery, Hong Kong, China
Institute of Integrated Bioinformedicine and Translational Science (IBTS), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
raw_author_name: Minchuan Lyu
raw_affiliation_strings: Guangdong-Hong Kong-Macao Greater Bay Area International Research Platform for Aptamer-Based Translational Medicine and Drug Discovery, Hong Kong, China
Institute of Integrated Bioinformedicine and Translational Science (IBTS), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
raw_author_name: Yumeng Liu
raw_affiliation_strings: Guangdong-Hong Kong-Macao Greater Bay Area International Research Platform for Aptamer-Based Translational Medicine and Drug Discovery, Hong Kong, China
Institute of Integrated Bioinformedicine and Translational Science (IBTS), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
raw_author_name: Meijun Liu
raw_affiliation_strings: Phenome Research Center, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
raw_author_name: Aiping Lyu
raw_affiliation_strings: Phenome Research Center, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. aipinglu@hkbu.edu.hk
Phenome Research Center, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
raw_author_name: Claudio Mauro
raw_affiliation_strings: College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK. c.mauro@bham.ac.uk
College of Medicine and Dental Sciences, University of Birmingham, Birmingham, UK
raw_author_name: Yuanyuan Yu
raw_affiliation_strings: Guangdong-Hong Kong-Macao Greater Bay Area International Research Platform for Aptamer-Based Translational Medicine and Drug Discovery, Hong Kong, China. yuyuanyuan@hkbu.edu.hk
Institute of Integrated Bioinformedicine and Translational Science (IBTS), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. yuyuanyuan@hkbu.edu.hk
Institute of Integrated Bioinformedicine and Translational Science (IBTS), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
Guangdong-Hong Kong-Macao Greater Bay Area International Research Platform for Aptamer-Based Translational Medicine and Drug Discovery, Hong Kong, China
raw_author_name: Kenneth CP Cheung
raw_affiliation_strings: Phenome Research Center, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China. kcpcheung@hkbu.edu.hk
Phenome Research Center, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China